CompletedNot Applicable

Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients

Canada232 participantsStarted 2015-11-19

Plain-language summary

The PROPhecy study aims to detect the presence of atrial fibrillation/flutter in patients who have suffered an embolic stroke of undetermined source (ESUS) using 30 day cardiac monitoring. We hypothesize that the presence of any of the following features on long-term heart rhythm monitoring (holter monitoring) or heart ultrasound (transthoracic echocardiogram), either individually or in combination, will have additional predictive value for the detection of atrial fibrillation lasting 30 seconds or longer on 30 day holter monitoring: * greater than 100 premature atrial beats in 24 hours * greater than 2 runs of atrial tachycardia (4 or more non-sinus beats) in 24 hours * Left atrial enlargement on transthoracic echocardiogram

Who can participate

Age range55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. An embolic arterial ischemic stroke confirmed by neuroimaging; or,
✓. A clinical transient ischemic attack, defined as involving a focal unilateral motor deficit, speech/language deficit, or hemianopia, with symptom duration \<24 hours (NOTE: amaurosis fugax/transient monocular blindness, pure sensory spells, isolated vertigo spells, etc. do not qualify for enrolment given the potential for misdiagnosis of such events).

What they're measuring

Detection of Atrial Fibrillation/Atrial Flutter

Timeframe: 30 days

Trial details

NCT IDNCT03712865

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-03

View on ClinicalTrials.gov More Embolic Stroke of Undetermined Source trials